Reports
Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.
Global Human Embryonic Stem Cell Market: By Application: Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering, Toxicology Testing; Regional Analysis; Historical Market and Forecast (2017-2027); Market Dynamics: SWOT Analysis; Value Chain Analysis; Competitive Landscape; Industry Events and Developments
Global Human Embryonic Stem Cell Market Outlook
The global human embryonic stem cell market reached a value of about USD 0.7 billion in 2020. The industry is further expected to grow at a CAGR of about 10% in the forecast period of 2022-2027 to reach a value of around USD 1.3 billion by 2026.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
North America to be a Significant Regional Market for Human Embryo Stem Cell
North America is a significant regional market in the human embryonic stem cell industry due to the presence of a major number of players and the high incidence of diseases, such as diabetes, heart disease, renal failure, and osteoporosis within the region. The large share can also be attributed to the increasing public-private funding and research grants for the development of safe and effective stem cell therapy products and the growing number of clinical trials. The United States has a high incidence of other diseases, such as diabetes, heart disease, renal failure, and osteoporosis. Human embryonic stem cells have a lot of potential for treatment and could become the global standard for these diseases. Additionally, the Food & Drug Administration (FDA) has approved clinical trials, which indicated the advantageous use of stem cells in treating such diseases. Hence, these factors are expected to influence the growth of the human embryonic stem cells industry over the forecast period. Meanwhile, the Asia Pacific is expected to grow at a robust rate due to the rapidly increasing population and the enhancement of the medical infrastructure in the region.
Human Embryonic Stem Cell: Market Segmentation
Human embryonic stem cell comes from embryos and are pluripotent and is about 3-5 days old. It is very versatile as it has the ability to divide itself into more stem cells and can even become any type of cell in the human body and can be used to regenerate or repair any diseased tissue or organs. The primary objective of stem cell therapy is to assist doctors in the treatment of neurodegenerative diseases, diabetes, and heart disease.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on application, the human embryonic stem cell industry is segmented into:
- Regenerative Medicine
- Stem Cell Biology Research
- Tissue Engineering
- Toxicology Testing
The regional markets for human embryonic stem cell can be divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Research and Development Activities Boosting the Market Growth of Human Embryonic Stem Cell
The advancements in technologies and growing research and development investments and research initiatives are expected to generate new opportunities for the market. As embryonic cells offer unmatched data related to a variety of diseases, researchers and scientists are increasingly leaning toward transforming the human embryonic stem cells into a range of mature cell types that represent different organs and tissues in the body. Advancements in stem culturing and derivation, along with rapid progress in laboratory technologies, are expected to play a key role in the overall growth of the global human embryonic stem cells industry during the forecast period. The rising prevalence of cardiac and malignant diseases around the world is expected to have a significant impact on demand and is anticipated to accelerate the market growth. Rapid advancements also include protocols for directed differentiation, defined culture systems, demonstration of applications in drug screening, and evaluation of therapeutic potential in treating incurable diseases. The demand for newer and better therapies to treat autoimmune, neurological, and cardiovascular diseases has resulted in an increase in research activities and funding for cell-based research, which is expected to favourably aid the growth of the human embryonic stem cell industry.
Key Industry Players in the Global Human Embryonic Stem Cell Market
The report gives a detailed analysis of the following key players in the global human embryonic stem cell market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
- Astellas Pharma Inc
- Stemcell Technologies Inc.
- Biotime, INC
- Thermo Fisher Scientific, Inc.
- Others
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2020 |
| Historical Period | 2017-2021 |
| Forecast Period | 2022-2027 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Application, Region |
| Breakup by Application | Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering, Toxicology Testing |
| Breakup by Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Market Dynamics | SWOT, Porter's Five Forces, Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | Astellas Pharma Inc, Stemcell Technologies Inc., Biotime, INC, Thermo Fisher Scientific, Inc., Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Human Embryonic Stem Cell Market Analysis
8.1 Key Industry Highlights
8.2 Global Human Embryonic Stem Cell Historical Market (2017-2021)
8.3 Global Human Embryonic Stem Cell Market Forecast (2022-2027)
8.4 Global Human Embryonic Stem Cell Market by Application
8.4.1 Regenerative Medicine
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2017-2021)
8.4.1.3 Forecast Trend (2022-2027)
8.4.2 Stem Cell Biology Research
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2017-2021)
8.4.2.3 Forecast Trend (2022-2027)
8.4.3 Tissue Engineering
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2017-2021)
8.4.3.3 Forecast Trend (2022-2027)
8.4.4 Toxicology Testing
8.4.4.1 Market Share
8.4.4.2 Historical Trend (2017-2021)
8.4.4.3 Forecast Trend (2022-2027)
8.5 Global Human Embryonic Stem Cell Market by Region
8.5.1 Market Share
8.5.1.1 North America
8.5.1.2 Europe
8.5.1.3 Asia Pacific
8.5.1.4 Latin America
8.5.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2017-2021)
9.1.2 Forecast Trend (2022-2027)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2017-2021)
9.2.2 Forecast Trend (2022-2027)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2017-2021)
9.3.2 Forecast Trend (2022-2027)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2017-2021)
9.4.2 Forecast Trend (2022-2027)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2017-2021)
9.5.2 Forecast Trend (2022-2027)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 Key Indicators for Demand
10.4 Key Indicators for Price
11 Value Chain Analysis
12 Competitive Landscape
12.1 Market Structure
12.2 Company Profiles
12.2.1 Astellas Pharma Inc
12.2.1.1 Company Overview
12.2.1.2 Product Portfolio
12.2.1.3 Demographic Reach and Achievements
12.2.1.4 Certifications
12.2.2 Stemcell Technologies Inc.
12.2.2.1 Company Overview
12.2.2.2 Product Portfolio
12.2.2.3 Demographic Reach and Achievements
12.2.2.4 Certifications
12.2.3 Biotime, INC
12.2.3.1 Company Overview
12.2.3.2 Product Portfolio
12.2.3.3 Demographic Reach and Achievements
12.2.3.4 Certifications
12.2.4 Thermo Fisher Scientific, Inc.
12.2.4.1 Company Overview
12.2.4.2 Product Portfolio
12.2.4.3 Demographic Reach and Achievements
12.2.4.4 Certifications
12.2.5 Others
13 Industry Events and Developments
List of Key Figures and Tables
1. Global Human Embryonic Stem Cell Market: Key Industry Highlights, 2016 and 2026
2. Global Human Embryonic Stem Cell Historical Market: Breakup by Application (USD Billion), 2017-2021
3. Global Human Embryonic Stem Cell Market Forecast: Breakup by Application (USD Billion), 2022-2027
4. Global Human Embryonic Stem Cell Historical Market: Breakup by Region (USD Billion), 2017-2021
5. Global Human Embryonic Stem Cell Market Forecast: Breakup by Region (USD Billion), 2022-2027
6. North America Human Embryonic Stem Cell Historical Market: Breakup by Country (USD Billion), 2017-2021
7. North America Human Embryonic Stem Cell Market Forecast: Breakup by Country (USD Billion), 2022-2027
8. Europe Human Embryonic Stem Cell Historical Market: Breakup by Country (USD Billion), 2017-2021
9. Europe Human Embryonic Stem Cell Market Forecast: Breakup by Country (USD Billion), 2022-2027
10. Asia Pacific Human Embryonic Stem Cell Historical Market: Breakup by Country (USD Billion), 2017-2021
11. Asia Pacific Human Embryonic Stem Cell Market Forecast: Breakup by Country (USD Billion), 2022-2027
12. Latin America Human Embryonic Stem Cell Historical Market: Breakup by Country (USD Billion), 2017-2021
13. Latin America Human Embryonic Stem Cell Market Forecast: Breakup by Country (USD Billion), 2022-2027
14. Middle East and Africa Human Embryonic Stem Cell Historical Market: Breakup by Country (USD Billion), 2017-2021
15. Middle East and Africa Human Embryonic Stem Cell Market Forecast: Breakup by Country (USD Billion), 2022-2027
16. Global Human Embryonic Stem Cell Market Structure
Key Questions Answered in the Report
In 2020, the global human embryonic stem cell market attained a value of nearly USD 0.7 billion.
The market is projected to grow at a CAGR of 10% between 2021 and 2026.
The market is estimated to witness a healthy growth in the forecast period of 2022-2027 to reach about USD 1.3 billion by 2026.
The major drivers of the market include the rapid progress in laboratory technologies, government investments, the prevalence of cardiac and malignant diseases, advancements in stem culturing and derivation, and the establishment of various disease models.
Rising research and development activities and advancement in technologies are the key industry trends propelling the growth of the market.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The leading applications segments in the industry are regenerative medicine, stem cell biology research, tissue engineering, and toxicology testing.
The major players in the industry are Astellas Pharma Inc, Stemcell Technologies Inc., Biotime, INC, and Thermo Fisher Scientific, Inc., among others.
Analyst Review
The global human embryonic stem cell market attained a value of nearly USD 0.7 billion in 2020, driven by the rising research and development activities and advancement in technologies. Aided by the development of laboratory technologies, the market is expected to witness a further growth in the forecast period of 2022-2027, growing at a CAGR of 10%. The market is projected to reach USD 1.3 billion by 2026.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. The major application segments in the industry are regenerative medicine, stem cell biology research, tissue engineering, and toxicology testing. The major regional markets for human embryonic stem cell are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market are Astellas Pharma Inc, Stemcell Technologies Inc., Biotime, INC, and Thermo Fisher Scientific, Inc., among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1499
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2699-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateFive User License
$3699-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4699-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
The global enzyme-linked immunosorbent assays (ELISAs) market was driven by the rising incidence of infectious diseases and cancer in the historical period. Aided by the growing applications of ELISA ...
The global bone morphogenetic proteins market was driven by the increasing number of people suffering from spinal injuries in the historical period. Aided by the rising geriatric population and establ...
The global blood group typing market attained a value of nearly USD 2 billion in 2021, driven by the growing demand for blood due to the rising cases of accidents. Aided by the rising awareness regard...
The global assisted reproductive technology market attained a value of USD 28.35 billion in 2021, driven by the increasing infertility cases. Aided by the rising consumption of unhealthy food and incr...
The global clinical laboratory services market was driven by the widening scope of clinical laboratory services in the historical period. Aided by the launch of technologically advanced products and a...
NEWSLETTER